Please try another search
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers SARS-CoV-2 antibody test strips; blood glucose monitors; bi-functional blood glucose monitors; point of care testing products; digital management tool solutions; non-invasive screening products; diabetes peripheral products; and PTS and Trividia Products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to approximately 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Hongjing Che | 51 | 2015 | Non-Independent Director |
Chungeng Chen | 47 | 2018 | Supervisor & Supply Chain Director |
Xixiong Kang | 72 | 2019 | Independent Director |
Shao Bo Li | 59 | 2002 | Chairman & GM |
Hong Yuan | 66 | 2019 | Independent Director |
Baishen Ouyang | 46 | 2016 | Chairman of the Supervisory Board & Assistant to the GM |
Hui Li | 41 | 2019 | Non-Independent Director |
Jizheng Chen | 48 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review